Skip Navigation


NDT Advance Access originally published online on January 23, 2006
Nephrology Dialysis Transplantation 2006 21(4):1109-1112; doi:10.1093/ndt/gfk098
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/4/1109    most recent
gfk098v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rudofsky, G.
Right arrow Articles by Schwenger, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rudofsky, G., Jr
Right arrow Articles by Schwenger, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Teaching Point
(Section Editor: A. Meyrier)

A nephrotic patient with tumour necrosis factor receptor-associated periodic syndrome, IgA nephropathy and CNS involvement

Gottfried Rudofsky, Jr1,{dagger}, Florian Hoffmann2,{dagger}, Klaus Müller3, Michael Filser1, Peter Lohse4, Jörg Beimler1 and Vedat Schwenger1

1 Department of Endocrinology and Nephrology, University of Heidelberg, 2 Department of Infectious Diseases and Immunology, Children's Hospital, University of Munich, 3 Department of Neuropathology, University of Freiburg and 4 Department of Clinical Chemistry – Großhadern, University of Munich, Germany

Correspondence and offprint requests to: Gottfried Rudofsky, MD, Division of Endocrinology and Nephrology, Department of Medicine, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany. Email: Gottfried_Rudofsky@med.uni-heidelberg.de

Keywords: amyloidosis; CNS manifestation; IgA nephropathy; periodic fever syndrome; TNF receptor-associated periodic syndrome

The first 150 words of the full text of this article appear below.



   Introduction
 
The periodic fever syndromes are a heterogeneous group of disorders characterized by repeated attacks of fever and localized inflammation, primarily affecting serosal surfaces, the skin and the musculoskeletal system [1]. To date, five periodic fever syndromes have been characterized on the basis of their clinical features. Except for the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome, the affected genes are known. Familial Mediterranean fever (FMF) caused by mutations in the Mediterranean fever (MEFV) gene, and the hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) due to mutations in the mevalonate kinase (MVK) gene have an autosomal recessive inheritance [1]. The others are autosomal dominant disorders: Cryopyrin-associated periodic syndrome (CAPS) as a consequence of heterozygous mutations in the cold-induced autoinflammatory syndrome 1 (CIAS1) gene, and the tumour necrosis factor receptor-associated periodic syndrome (TRAPS) caused by dominantly inherited mutations in the . . . [Full Text of this Article]



   Case
 


   Discussion
 


   Teaching points
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NeurologyHome page
L. A. Hoffmann, P. Lohse, F. B. Konig, W. Feneberg, R. Hohlfeld, and T. Kumpfel
TNFRSF1A R92Q MUTATION IN ASSOCIATION WITH A MULTIPLE SCLEROSIS-LIKE DEMYELINATING SYNDROME
Neurology, March 25, 2008; 70(13_Part_2): 1155 - 1156.
[Full Text] [PDF]

Home page
 NeurologyHome page
B. Wildemann, G. Rudofsky Jr, B. Kress, S. Jarius, F. Konig, and V. Schwenger
THE TUMOR NECROSIS FACTOR-ASSOCIATED PERIODIC SYNDROME, THE BRAIN, AND TUMOR NECROSIS FACTOR-{alpha} ANTAGONISTS
Neurology, May 15, 2007; 68(20): 1742 - 1744.
[Full Text] [PDF]